The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Open accessAbstract
After tissue damage, inflammatory cells infiltrate the tissue and release proinflammatory cytokines. HMGB1 (high mobility group box 1), a nuclear protein released by necrotic and severely stressed cells, promotes cytokine release via its interaction with the TLR4 (Toll-like receptor 4) receptor and cell migration via an unknown mechanism. We show that HMGB1-induced recruitment of inflammatory cells depends on CXCL12. HMGB1 and CXCL12 form a heterocomplex, which we characterized by nuclear magnetic resonance and surface plasmon resonance, that acts exclusively through CXCR4 and not through other HMGB1 receptors. Fluorescence resonance energy transfer data show that the HMGB1–CXCL12 heterocomplex promotes different conformational rearrangements of CXCR4 from that of CXCL12 alone. Mononuclear cell recruitment in vivo into air pouches and injured muscles depends on the heterocomplex and is inhibited by AMD3100 and glycyrrhizin. Thus, inflammatory cell recruitment and activation both depend on HMGB1 via different mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
Self-citationRetractedInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“Stress conditions that induce HMGB1 secretion include hypoxia (Andrassy et al., 2008), treatment with specific antitumor drugs (Ditsworth et al., 2007), or lethal irradiation (Apetoh et al., 2007).”
BackgroundFunction of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Endogenous HMGB1 regulates autophagy
Tang, D., Kang, R., Livesey, K. M., Cheh, C.-W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911078 · Cited by 951
Self-citationMaroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2127 · Cited by 842
Self-citationYang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
Crump, M. P., Gong, J., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana‐Seisdedos, F., Virelizier, J., Baggiolini, M., Sykes, B. D., & Clark‐Lewis, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6996 · Cited by 731 · cited 3×
“Residues 3–12 in the N terminus of CXCL12, which are directly involved in CXCR4 recognition and triggering (Crump et al., 1997), were affected by the binding of full-length HMGB1 but not of either BoxA or BoxB alone (Fig.”
BackgroundHigh-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S., Autschbach, F., Pleger, S. T., Lukic, I. K., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769331 · Cited by 620
Self-citationTsung, A., Klune, J. R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D. B., Geller, D. A., Rosengart, M. R., & Billiar, T. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070247 · Cited by 620
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Ivanov, S., Dragoi, A.-M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044776 · Cited by 470
Self-citationDegryse, B., Bonaldi, T., Scaffidi, P., Müller, S., Resnati, M., Sanvito, F., Arrigoni, G., & Bianchi, M. E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1197 · Cited by 451
Self-citationLoetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., & Moser, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42339-8 · Cited by 445
Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Bianchi, M. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008585 · Cited by 416
Self-citationHMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
Sha, Y., Zmijewski, J., Xu, Z., & Abraham, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2531 · Cited by 393
A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrin
Orlova, V. V., Choi, E. Y., Xie, C., Chavakis, E., Bierhaus, A., Ihanus, E., Ballantyne, C. M., Gahmberg, C. G., Bianchi, M. E., Nawroth, P. P., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601552 · Cited by 381
Self-citationYang, D., Chen, Q., Yang, H., Tracey, K. J., Bustin, M., & Oppenheim, J. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306180 · Cited by 380
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
Self-citationUguccioni, M., D'Apuzzo, M., Loetscher, M., Dewald, B., & Baggiolini, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250113 · Cited by 346
Self-citationInternational Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature
Murphy, P. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.227 · Cited by 342
Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., & Heveker, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411151200 · Cited by 261
Zimmermann, T., Rietdorf, J., Girod, A., Georget, V., & Pepperkok, R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03508-1 · Cited by 241
Jujo, K., Hamada, H., Iwakura, A., Thorne, T., Sekiguchi, H., Clarke, T., Ito, A., Misener, S., Tanaka, T., Klyachko, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914248107 · Cited by 214
Ditsworth, D., Zong, W.-X., & Thompson, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701465200 · Cited by 208
Agace, W. W., Amara, A., Roberts, A. I., Pablos, J. L., Thelen, S., Uguccioni, M., Li, X. Y., Marsal, J., Arenzana-Seisdedos, F., Delaunay, T., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00380-8 · Cited by 198
Self-citationAutophagy inhibition in combination cancer treatment.
Livesey, K. M., Tang, D., Zeh, H. J., & Lotze, M. T. (2009) · PubMed · Cited by 173
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
Sitia, G., Iannacone, M., Müller, S., Bianchi, M. E., & Guidotti, L. G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306173 · Cited by 139
Self-citationThe role of HMGB1 in the pathogenesis of rheumatic disease
Andersson, U., & Harris, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.003 · Cited by 137
Kupffer Cells Hasten Resolution of Liver Immunopathology in Mouse Models of Viral Hepatitis
Sitia, G., Iannacone, M., Aiolfi, R., Isogawa, M., van Rooijen, N., Scozzesi, C., Bianchi, M. E., von Andrian, U. H., Chisari, F. V., & Guidotti, L. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002061 · Cited by 130
Self-citationCampana, L., Bosurgi, L., Bianchi, M. E., Manfredi, A. A., & Rovere, P. Q. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908576 · Cited by 126
Self-citationKnapp, S., Müller, S., Digilio, G., Bonaldi, T., Bianchi, M. E., & Musco, G. (2004) · Biochemistry · doi:10.1021/bi049364k · Cited by 120
Self-citationA rich chemokine environment strongly enhances leukocyte migration and activities
Paoletti, S., Petkovic, V., Sebastiani, S., Danelon, M. G., Uguccioni, M., & Gerber, B. O. (2004) · Blood · doi:10.1182/blood-2004-04-1648 · Cited by 110
Self-citationPenzo, M., Molteni, R., Suda, T., Samaniego, S., Raucci, A., Habiel, D. M., Miller, F. W., Jiang, H.-P., Li, J., Pardi, R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903131 · Cited by 106
Self-citationVenetz, D., Ponzoni, M., Schiraldi, M., Ferreri, A. J. M., Bertoni, F., Doglioni, C., & Uguccioni, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25236 · Cited by 99
Self-citationChemical synthesis, purification, and folding of C-X-C and C-C chemokines
Clark‐Lewis, I., Vo, L., Owen, P., & Anderson, J. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)87018-8 · Cited by 61
Src family kinases are necessary for cell migration induced by extracellular HMGB1
Palumbo, R., Marchis, F. D., Pusterla, T., Conti, A., Alessio, M., & Bianchi, M. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908581 · Cited by 61
Self-citationDynamic Regulation of CXCR1 and CXCR2 Homo- and Heterodimers
Martínez‐Muñoz, L., Lucas, P., Navarro, G., Checa, A. I., Franco, R., Martínez‐A, C., Rodrı́guez-Frade, J. M., & Mellado, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901802 · Cited by 55
Self-citationSolution mapping of T cell receptor docking footprints on peptide-MHC
Varani, L., Bankovich, A. J., Liu, C. W., Colf, L. A., Jones, L. L., Kranz, D. M., Puglisi, J. D., & García, K. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703702104 · Cited by 46
Self-citation
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Metadata
- Authors
- Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., Thelen, M., Varani, L., Mellado, M., Proudfoot, A., Bianchi, M. E., & Uguccioni, M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-02-27
- Volume
- 209
- Issue
- 3
- Pages
- 551-563
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2132280604
- Cited by
- 676
- References
- 47
- FWCI
- 27.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.